Micro Therapeutics Medtronic Solitaire X Revascularization Device - HSA Registration DE0505475
Access comprehensive regulatory information for Micro Therapeutics Medtronic Solitaire X Revascularization Device in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0505475 and owned by Micro Therapeutics, Inc. d/b/a ev3 Neurovascular. The device was registered on February 17, 2021.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Solitaire™ X Revascularization Device is designed for use in the flow restoration of patients with ischemic stroke due to large intracranial vessel occlusion. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA) or who fail IV t-PA therapy are candidates for treatment. The Solitaire™ X Revascularization Device should only be used by physicians trained in interventional neuroradiology and treatment of ischemic stroke